Innovating
from research to marketing
Each year, LIPHATECH allocates substantial investment (between 15% and 20% of annual turnover) in creating innovative products. The highly regulated process to bring these products to market goes through numerous stages.
See how LIPHATECH controls the entire chain in eight key stages
















Basicresearch
Basic research underpins LIPHATECH’s success.
The company’s expertise in chemistry and biology and its patents for anticoagulants make it a leader in rodent control. For LIPHATECH, basic research is a driving factor of innovation.